Results 21 to 30 of about 53,302 (297)

Botulinum Toxin Type A for Lumbar Sympathetic Ganglion Block in Complex Regional Pain Syndrome: A Randomized Trial

Anesthesiology, 2021
Background: The present study was designed to test the hypothesis that botulinum toxin would prolong the duration of a lumbar sympathetic block measured through a sustained increase in skin temperature.
Y. Yoo, Chang-Soon Lee, Jungsoo Kim, Dongwon Jo, J. Moon   +4 more
semanticscholar   +1 more source

Botulinum toxin type A therapy for hemifacial spasm.

Cochrane Database of Systematic Reviews, 2020
BACKGROUND This is an update of a Cochrane Review, first published in 2005. Hemifacial spasm (HFS) is characterised by unilateral, involuntary contractions of the muscles innervated by the facial nerve.
G. Duarte, Filipe B Rodrigues, Mafalda Castelão, Raquel E Marques, J. Ferreira, C. Sampaio, A. P. Moore, J. Costa   +7 more
semanticscholar   +1 more source

The Effect of Botulinum Toxin Type A in Patients with Essential Blepharospasm

Acta Clinica Croatica, 2022
The aim of this study was to determine the effect of botulinum toxin type A and satisfaction in patients with essential blepharospasm. The study included 12 subjects suffering from essential blepharospasm who received therapy with botulinum toxin type ...
Klara Gaćina, Mladen Lešin, Dean Sarajčev, Nina Rotim   +3 more
doaj   +1 more source

Pulsed dye laser followed by intradermal botulinum toxin type‐A in the treatment of rosacea‐associated erythema and flushing

Dermatologic Therapy, 2020
Rosacea is a common inflammatory skin disease characterized by erythema, episodes of flushing, and inflammatory lesions. It typically affects the face and is more prevalent among fair skin individuals affecting women more than men. Various treatments are
F. Al‐Niaimi, E. Glagoleva, E. Araviiskaia   +2 more
semanticscholar   +1 more source

Arrangement of the Clostridium baratii F7 toxin gene cluster with identification of a σ factor that recognizes the botulinum toxin gene cluster promoters.

PLoS ONE, 2014
Botulinum neurotoxin (BoNT) is the most poisonous substances known and its eight toxin types (A to H) are distinguished by the inability of polyclonal antibodies that neutralize one toxin type to neutralize any of the other seven toxin types.
Nir Dover, Jason R Barash, Julianne N Burke, Karen K Hill, John C Detter, Stephen S Arnon   +5 more
doaj   +1 more source

Botulinum Toxin Type a in Cervical Dystonia

International Journal of Immunopathology and Pharmacology, 2012
Cervical dystonia is a syndrome characterized by anomalous postures and unintentional repetitive movements of the head and the neck. Aim of this study is to show the effectiveness of the combined treatment botulinum toxin-FKT through the use of a recent methodic of investigation, myoton, and of the classical clinical evaluations, such as Tsui and VAS ...
Marvulli R., Ianieri G., Megna G., Lancioni G., SAGGINI, Raoul, Ranieri M., Cristella G., Megna M.   +7 more
openaire   +3 more sources

The efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis: a systematic review and meta-analysis

Journal of International Medical Research, 2020
Objective A systematic review and meta-analysis was carried out to evaluate the efficacy and safety of Botulinum Toxin Type A in painful knee osteoarthritis. Methods The EMBASE and MEDLINE databases were searched to identify randomized controlled trials (
Shuchao Zhai, Botao Huang, Kai Yu
doaj   +1 more source

Diagnostic nerve block in prediction of outcome of botulinum toxin treatment for spastic equinovarus foot after stroke: A retrospective observational study

Journal of Rehabilitation Medicine, 2020
Objective: To evaluate the role of diagnostic nerve block in predicting the outcome of subsequent botulinum toxin type A treatment for spastic equinovarus foot due to chronic stroke. Design: Retrospective observational study.
Alessandro Picelli, Elisa Battistuzzi, Mirko Filippetti, Angela Modenese, Marialuisa Gandolfi, Daniele Munari, Nicola Smania   +6 more
doaj   +1 more source

Botulinum Toxin Type A for the Treatment of Post-traumatic Headache: A Randomized, Placebo-Controlled, Cross-over Study.

Military Medicine, 2020
INTRODUCTION Botulinum toxin type A (BoNT/A) is an approved treatment for chronic migraine and has been shown to be effective in reducing number, days, and severity of headache in other headache disorders.
M. Zirovich, S. Pangarkar, C. Manh, Lucia Chen, S. Vangala, D. Elashoff, I. S. Izuchukwu   +6 more
semanticscholar   +1 more source

Intra-sphincteric botulinum toxin in the management of functional biliary pain

Endoscopy International Open, 2022
Background and study aims The management of functional biliary-type pain remains a clinical challenge. Intra sphincteric botulinum toxin putatively exerts an anti-spasmodic and anti-nociceptive effect.
Shyam Menon, Andrew Holt, Adam D. Farmer
doaj   +1 more source